Evaluate Mobile Computing Devices in a Well Characterized Longitudinal Clinical Research Population
About the Research Project
Program
Award Type
Bold Ideas initiatives
Award Amount
$50,000
Active Dates
April 01, 2013 - December 31, 2015
Grant ID
C2013210
Summary
Computer based testing of cognition is a rapidly evolving field. Cognitive impairment differs between diseases. By testing individual applications, this study is designed to ensure that Alzheimer’s patient’s unique cognitive and individual features can be monitored in the most high tech mobile applications.
This study pairs a sophisticated mobile health assessment tool with clinical rigor available in long-standing longitudinal trials. In this project, investigators are asking whether the feedback provided by the mobile application is consistent with the gold-standard clinical evaluations that are possible in a neurologists office.
Related Grants
Alzheimer's Disease Research
CARE Consortium Biobank
Active Dates
May 01, 2025 - April 30, 2026
Principal Investigator
Thomas Mcallister, MD
Current Organization
Indiana University
CARE Consortium Biobank
Active Dates
May 01, 2025 - April 30, 2026
Principal Investigator
Thomas Mcallister, MD
Current Organization
Indiana University
Alzheimer's Disease Research
Expanding and Enhancing LASI-DAD for Better Understanding of Alzheimer's Disease and Dementia
Active Dates
April 01, 2023 - March 31, 2025
Principal Investigator
Jinkook Lee, PhD
Current Organization
University of Southern California
Expanding and Enhancing LASI-DAD for Better Understanding of Alzheimer's Disease and Dementia
Active Dates
April 01, 2023 - March 31, 2025
Principal Investigator
Jinkook Lee, PhD
Current Organization
University of Southern California
Alzheimer's Disease Research
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024
Principal Investigator
William Korinek, PhD
Current Organization
Astrocyte Pharmaceuticals
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024
Principal Investigator
William Korinek, PhD
Current Organization
Astrocyte Pharmaceuticals